Bard (company)

Solventum Names Shirley Edwards to Board of Directors

Retrieved on: 
Monday, April 15, 2024
Organization, Capital, EY, Covidien, AbbVie, Girl Guides, NASA, Bard (company), Nation, Mondelez International, Appian Corporation, Labcorp, American Red Cross, Talent, SOLV, Audit, Growth, Management

ST. PAUL, Minn., April 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its Board of Directors appointed Shirley Edwards, former partner, EY, to the board.

Key Points: 
  • ST. PAUL, Minn., April 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its Board of Directors appointed Shirley Edwards, former partner, EY, to the board.
  • "We are excited to welcome Shirley to our Board of Directors.
  • "Shirley joins a robust board that brings deep expertise across healthcare, strategy and finance.
  • We are ready to bring forward Solventum's mission of enabling better, smarter, safer health care to improve lives," said Carrie Cox, chairman of the Board of Directors, Solventum.

Elevage Medical Technologies Continues Expansion of Investment Team and Board

Retrieved on: 
Tuesday, February 27, 2024
Frazier Healthcare Partners, Teleflex, Investment, Biological engineering, Mechanical, MIT, Invention, Growth, National academy, MBA, Senior advisor, Revelation, Biomedicine, Mechanical engineering, Patent, Bard (company), Needham & Company, Yale University, Acclarent, Medtronic, Columbia University, American Institute, Management

AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ -- Elevage Medical Technologies ("Elevage"), a portfolio company of Patient Square Capital, dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board. Vice-Presidents Suchira Sharma and Peter Tortora join the Elevage investment team, along with Dr. Josh Makower, a Senior Advisor to Patient Square and Elevage, who will also join the Elevage Board of Directors.

Key Points: 
  • hires –
    AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ -- Elevage Medical Technologies ("Elevage"), a portfolio company of Patient Square Capital , dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board.
  • Vice-Presidents Suchira Sharma and Peter Tortora join the Elevage investment team, along with Dr. Josh Makower, a Senior Advisor to Patient Square and Elevage, who will also join the Elevage Board of Directors.
  • Dr. Evan Melrose, CEO of Elevage Medical, said, "We are thrilled with these three key additions to the Elevage team.
  • Dr. Makower is also the Founder & Executive Chairman of ExploraMed, a medical device incubator that has created eleven companies since 1995.

SeaStar Medical Appoints David A. Green as Chief Financial Officer

Retrieved on: 
Thursday, January 11, 2024
Bard (company), Death, Duff, Duff & Phelps, Therapy, State university system, Intarcia Therapeutics, State, CFO, Certified Public Accountant, University, Interim management, MBA, Interim, Growth, Pharmaceutical industry

Green as Chief Financial Officer, effective January 10, 2024.

Key Points: 
  • Green as Chief Financial Officer, effective January 10, 2024.
  • Caryl Baron, who has served as Interim CFO since October 2022, will continue with SeaStar Medical as Vice President of Finance.
  • “We welcome David to our executive team at this critical time as we prepare for our first commercial launch for the Selected Cytopheretic Device Pediatric (SCD-PED) later this quarter,” said Eric Schlorff, CEO of SeaStar Medical.
  • Earlier, he was Chief Accounting Officer at Intarcia Therapeutics, a commercial-stage biopharmaceutical company; CFO of Catheter Connections, a commercial-stage medical device company acquired by Merit Medical; and CFO of Specialized Health Products International, a publicly traded medical device company acquired by C.R.

Dr. Stephen Oesterle and Dr. Joshua Makower Join Patient Square Capital as Senior Advisors

Retrieved on: 
Thursday, January 4, 2024
Paragon, Acclarent, Mechanical engineering, Health, Yale School of Medicine, Stanford University, Patent, Biological engineering, SVP, Teleflex, Bard (company), Baxter International, MIT, American Institute, MBA, Columbia University, CeramTec, National academy, Mechanical, Yale school, Flexner Report, Friends, Therapy, Invention, Biomedicine, Patient, Harvard Medical School, Hospital, MD, Medtronic, Investment, Harvard College, Interventional cardiology, Nursing

MENLO PARK, Calif., Jan. 4, 2024 /PRNewswire/ -- Patient Square Capital , a leading health care investment firm, today announced that Dr. Joshua Makower and Dr. Stephen Oesterle joined as Senior Advisors to the firm.

Key Points: 
  • MENLO PARK, Calif., Jan. 4, 2024 /PRNewswire/ -- Patient Square Capital , a leading health care investment firm, today announced that Dr. Joshua Makower and Dr. Stephen Oesterle joined as Senior Advisors to the firm.
  • Dr. Makower will also be joining the board of Elevage Medical Technologies, a Patient Square portfolio company focused on growth-stage medical technologies.
  • "Dr. Oesterle and Dr. Makower are undisputed leaders, innovators, and investors in the medical technology space," said Neel Varshney, M.D., Founding Partner of Patient Square.
  • "The resources Patient Square has assembled for the ultimate goal of improving patient outcomes are transformational," added Dr. Oesterle.

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

Retrieved on: 
Wednesday, December 13, 2023
Pharmacia, NPO, Trust, Heitman, Trustee, Healthpeak Properties, National Association, Tyco International, Therapy, EGP, University, JCI, UE, Toll Brothers, PEAK, Bard (company), Management

FORT WASHINGTON, Pa., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE: TOL) ( TollBrothers.com ), the nation’s leading builder of luxury homes, today announced that Judith A. Reinsdorf and Katherine M. Sandstrom have joined the Company’s Board of Directors.

Key Points: 
  • FORT WASHINGTON, Pa., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE: TOL) ( TollBrothers.com ), the nation’s leading builder of luxury homes, today announced that Judith A. Reinsdorf and Katherine M. Sandstrom have joined the Company’s Board of Directors.
  • She is also on the Board of Trustees of the University of Rochester and the board of the New Jersey Chapter of the National Association of Corporate Directors.
  • Douglas C. Yearley, Jr., chairman and chief executive officer, stated: “We are very pleased and excited to welcome both Judy and Kathy to the Toll Brothers Board of Directors.
  • We wish him all the best and are deeply appreciative of his many years of distinguished service to Toll Brothers.”

Global Vascular Access Devices (MedSuite) Market Size, Share & Trends Analysis 2024-2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, November 17, 2023
Medical Supplies, Medical Devices, Health, Surgery, Cardiology, Biotechnology, PICC, Teleflex, Central venous catheter, Acquisition, Research, BD (company), Risk, Catheter, Peripherally inserted central catheter, CVC, Growth, Bard (company), Medical imaging, Medical device

The "Global Vascular Access Devices Market Size, Share & Trends Analysis 2024-2030 - MedSuite" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Vascular Access Devices Market Size, Share & Trends Analysis 2024-2030 - MedSuite" report has been added to ResearchAndMarkets.com's offering.
  • While this MedSuite report provides a comprehensive overview of the Global Vascular Access Devices market, you also have the option to access each market segment individually as stand-alone MedCore reports.
  • The global vascular access device market is on the brink of substantial expansion, and long-term devices like implantable ports, CVCs, and PICCs are emerging as the primary drivers of this growth.
  • In 2023, Becton Dickinson continued to maintain its dominant position as the leader in the global vascular access device and accessories market.

AliveCor Appoints Michael Rolla as Chief Revenue Officer, Enterprise

Retrieved on: 
Friday, November 10, 2023
CCS, ECG, BD (company), Growth, Bard (company), Alivecor, Teladoc Health, FDA, Management

MOUNTAIN VIEW, Calif., Nov. 10, 2023 /PRNewswire/ -- AliveCor , the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the appointment of Michael Rolla, who will serve as AliveCor's Chief Revenue Officer, Enterprise.

Key Points: 
  • MOUNTAIN VIEW, Calif., Nov. 10, 2023 /PRNewswire/ -- AliveCor , the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the appointment of Michael Rolla, who will serve as AliveCor's Chief Revenue Officer, Enterprise.
  • Rolla will provide strategic leadership for AliveCor's employer, payor, biopharma and healthcare provider enterprise businesses.
  • Rolla is a seasoned leader who has adeptly navigated the intricate landscape of healthcare technology, consistently delivering transformative results.
  • Having previously served as the Chief Growth Officer for CCS and later as the Chief Revenue Officer of UpHealth Inc., Rolla played a pivotal role in shaping growth and influence in public and private sectors.

VirTra Appoints Tony Cianflone as VP of Sales

Retrieved on: 
Tuesday, October 24, 2023
Firearm, History, Anthony Cianflone, Organization, Acquisition, Intuitive Surgical, Law enforcement, State University of New York College of Environmental Science and Forestry, Economics, State university system, Bard (company), Sales

(Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators, firearms training simulators for the law enforcement and military markets, today announced the appointment of Tony Cianflone as Vice President of Sales, effective October 23, 2023.

Key Points: 
  • (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators, firearms training simulators for the law enforcement and military markets, today announced the appointment of Tony Cianflone as Vice President of Sales, effective October 23, 2023.
  • With over 25 years of professional sales leadership experience, Tony Cianflone brings a proven track record of success to his new role at VirTra.
  • His expertise lies in sales leadership, sales process optimization, talent acquisition, training, and the development of teams and individuals to consistently exceed sales quotas.
  • These strategic sales initiatives, combined with a continued focus on content creation and new product development, position VirTra for heightened success moving forward.

BERGER MONTAGUE SHAREHOLDER SHANON J. CARSON AND SENIOR COUNSEL JENNIFER P. ELWELL APPOINTED TO LEADERSHIP POSITIONS IN THE BARD IMPLANTED PORT CATHETER MDL LITIGATION

Retrieved on: 
Tuesday, September 26, 2023
Infection, Thrombosis, Bard, Arrhythmia, Telephone, Medicine, Plaintiff, Fungus, Sale, MDL Information Systems, Sepsis, MDL, Amputation, District court, Bleeding, Collection, Bard (company), Risk, BD (company), Fracture, Pelvic floor dysfunction, Death, Douglas v. U.S. District Court ex rel Talk America, Barium sulfate, Skin, Injury, Medical device

The court appointed Mr. Carson to the Plaintiffs' Executive Committee and Ms. Elwell to the Plaintiffs' Steering Committee.

Key Points: 
  • The court appointed Mr. Carson to the Plaintiffs' Executive Committee and Ms. Elwell to the Plaintiffs' Steering Committee.
  • Berger Montague has been contacted by hundreds of individuals alleging injuries by Bard port catheters.
  • Bard port catheters are surgically placed under the skin, typically in the chest, and consist of an injection port and a catheter.
  • Please direct all inquiries to Berger Montague's Bard Port Catheter Litigation Team by email to [email protected] or by telephone at (215) 875-3072.

Azenta Announces CFO Transition

Retrieved on: 
Tuesday, September 26, 2023
Bachelor of Science in Information Technology, Operation, Small business, Bard (company), Senior, Certified Public Accountant, Fairleigh Dickinson University, Becton, Dickinson and Company headquarters, Business administration, Secretary of State of New Jersey, Retirement, Acquisition, Becton, Master of Business Administration, Seton Hall University, BDX, NYSE, Management, Science, Finance, Azenta

BURLINGTON, Mass., Sept. 26, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Herman Cueto will join Azenta as Executive Vice President and Chief Financial Officer, effective October 16. Mr. Cueto, who comes from BD (Becton, Dickinson and Company, NYSE: BDX), will succeed Azenta CFO Lindon Robertson, who is retiring and will remain as an advisor to facilitate a seamless transition.

Key Points: 
  • BURLINGTON, Mass., Sept. 26, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Herman Cueto will join Azenta as Executive Vice President and Chief Financial Officer, effective October 16.
  • Mr. Cueto, who comes from BD (Becton, Dickinson and Company, NYSE: BDX), will succeed Azenta CFO Lindon Robertson, who is retiring and will remain as an advisor to facilitate a seamless transition.
  • Steve Schwartz, Azenta President and Chief Executive Officer, said, "We are thrilled to welcome Herman to Azenta.
  • Azenta is reaffirming its fourth quarter fiscal 2023 guidance provided in its third quarter 2023 earnings materials on August 8, 2023.